Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 8Observational 5

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 2929Neoplasms 2624Lung Neoplasms 1366Colorectal Neoplasms 1328Prostatic Neoplasms 1214Carcinoma, Non-Small-Cell Lung 1079Carcinoma, Hepatocellular 782Stomach Neoplasms 720Pancreatic Neoplasms 701Ovarian Neoplasms 586Colonic Neoplasms 533Uterine Cervical Neoplasms 497Head and Neck Neoplasms 495Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 422Neoplasm Metastasis 418Brain Neoplasms 404Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Urinary Bladder Neoplasms 386Leukemia, Myeloid, Acute 385Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 312Recurrence 298Disease 272

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Immunotherapy × Clear all
NCT05909137 2025-07-14

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Xinqiao Hospital of Chongqing

Not yet recruiting
60 enrolled
Thoracic

Immunotherapy

NCT06946745 2025-04-27

Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Recruiting
50 enrolled

Immunotherapy

NCT06276088 2024-03-15

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Nanfang Hospital, Southern Medical University

Recruiting
374 enrolled

Immunotherapy

NCT05719324 2023-02-10

Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study

The First Affiliated Hospital with Nanjing Medical University

Unknown
200 enrolled

Immunotherapy

NCT04587817 2020-10-14

Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors

Peking University First Hospital

Unknown
60 enrolled

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡